Nucleocapsid protein

Nucleocapsid protein Overview

English NameNucleocapsid proteinsApproved Drugs0
Drugs in Clinical Trials2Target SynonymNucleocapsid Proteins
Highest Development StagePhase 2 Clinical
English NameNucleocapsid proteins
Target SynonymNucleocapsid Proteins
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

Nucleocapsid protein Product List

  • Product Category

    Protein (20)Kits (1)

  • Product Status

    Launched (21)

  • Species

    SARS-CoV-2 (15)MERS (1)SARS (1)HCoV-NL63 (1)HCoV-OC43 (1)HCoV-229E (1)SFTS virus (1)

  • Tag

    His Tag (18)His Tag & Avi Tag (2)- (1)

  • Conjugate

    Unconjugated (18)Biotin-labeled (2)- (1)

Nucleocapsid protein Background

Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.

Nucleocapsid protein Synonyms

Nucleocapsid protein,NP,Protein N

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ZelicapavirEDP-938; EP-023938Phase 2 ClinicalEnanta Pharmaceuticals IncRespiratory Syncytial Virus Infections
Details
PF-07923567RV-299; PF-07923567Phase 1 ClinicalReviral LtdRespiratory Syncytial Virus Infections
Details
  • Overview
  • Product List
  • Clinical Drug Information